PERSPECTA

News from every angle

Back to headlines

Medicare Drug Price Controls Could Raise Prices Long-Term

New research suggests that Medicare's drug price controls, intended to save taxpayers over $100 billion, could paradoxically lead to higher prices in the long run.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.